During his visit, Gyawali is expected to get a clear commitment from New Delhi for supply of over 12 million doses of the coronavirus vaccines produced in India. Nepal has offers from China to supply its version of the Sinovac vaccine. During discussions with Indian officials, Nepalese officials have, however, said that the Oli government preferred to get its vaccine supplies from New Delhi.
Nepal’s ambassador to India Nilamber Acharya has already held several rounds of meetings with Indian vaccine manufacturers and government officials. His last meeting was on Tuesday with Dr V Krishna Mohan, executive director of Bharat Biotech that is producing the indigenously-developed Covid 19 vaccine.
China, which has poured millions of dollars into Nepal in recent years in the form of aid and infrastructure investment, appears to have exhausted its influence with PM Oli in recent months after it tried to pressure him to avoid splitting the ruling communist party at all costs. Beijing is lately seen to be leaning in support of the rival communist party faction led by Prachanda and Madhav Nepal.